The clinical presentation of coronavirus disease 2019 (COVID-19) ranges from mild flu-like symptoms in many patients to severe respiratory failure and death in patients with comorbidities. Although studies have shown correlations between hyperactivation of the immune system and the formation of a cytokine storm in patients with severe COVID-19, the host genetic factors that rule these immune events and determine the susceptibility of some patients to severe disease is not well understood.
